Publications

A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer's disease and MCI patients: implications for regenerative medicine approaches  (2017)

Authors:
Morena, Francesco; Argentati, Chiara; Trotta, Rosa; Crispoltoni, Lucia; Stabile, Anna; Pistilli, Alessandra; di Baldassarre, Angela; Calafiore, Riccardo; Montanucci, Pia; Basta, Giuseppe; Pedrinolla, Anna; Smania, Nicola; Venturelli, Massimo; Schena, Federico; Naro, Fabio; Emiliani, Carla; Rende, Mario; Martino, Sabata
Title:
A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer's disease and MCI patients: implications for regenerative medicine approaches
Year:
2017
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
Elettronico
Referee:
Name of journal:
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
ISSN of journal:
1422-0067
N° Volume:
18
Number or Folder:
8
Page numbers:
1-18
Keyword:
Cathepsin B; Cathepsin D; Cathepsin L; Cathepsin S; aging; dementia; neurodegeneration; β-Galactosidase; β-Galactosylcebrosidase; β-Glucuronidase; β-Hexosaminidase
Short description of contents:
The association of lysosomal dysfunction and neurodegeneration has been documented in several neurodegenerative diseases, including Alzheimer's Disease (AD). Herein, we investigate the association of lysosomal enzymes with AD at different stages of progression of the disease (mild and severe) or with mild cognitive impairment (MCI). We conducted a screening of two classes of lysosomal enzymes: glycohydrolases (β-Hexosaminidase, β-Galctosidase, β-Galactosylcerebrosidase, β-Glucuronidase) and proteases (Cathepsins S, D, B, L) in peripheral blood samples (blood plasma and PBMCs) from mild AD, severe AD, MCI and healthy control subjects. We confirmed the lysosomal dysfunction in severe AD patients and added new findings enhancing the association of abnormal levels of specific lysosomal enzymes with the mild AD or severe AD, and highlighting the difference of AD from MCI. Herein, we showed for the first time the specific alteration of β-Galctosidase (Gal), β-Galactosylcerebrosidase (GALC) in MCI patients. It is notable that in above peripheral biological samples the lysosomes are more sensitive to AD cellular metabolic alteration when compared to levels of Aβ-peptide or Tau proteins, similar in both AD groups analyzed. Collectively, our findings support the role of lysosomal enzymes as potential peripheral molecules that vary with the progression of AD, and make them useful for monitoring regenerative medicine approaches for AD.
Web page:
https://doi.org/10.3390/ijms18081806
Product ID:
98711
Handle IRIS:
11562/967698
Last Modified:
November 9, 2022
Bibliographic citation:
Morena, Francesco; Argentati, Chiara; Trotta, Rosa; Crispoltoni, Lucia; Stabile, Anna; Pistilli, Alessandra; di Baldassarre, Angela; Calafiore, Riccardo; Montanucci, Pia; Basta, Giuseppe; Pedrinolla, Anna; Smania, Nicola; Venturelli, Massimo; Schena, Federico; Naro, Fabio; Emiliani, Carla; Rende, Mario; Martino, Sabata, A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer's disease and MCI patients: implications for regenerative medicine approaches «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES» , vol. 18 , n. 82017pp. 1-18

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share